Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality
EC Vamvakas, MA Blajchman - Transfusion medicine reviews, 2010 - Elsevier
After reviewing the relative frequency of the causes of allogeneic blood transfusion-related
mortality in the United States today, we present 6 possible strategies for further reducing …
mortality in the United States today, we present 6 possible strategies for further reducing …
Buffy‐coat‐derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
H Schrezenmeier, E Seifried - Vox sanguinis, 2010 - Wiley Online Library
There is an ongoing debate whether platelet concentrates (PCs) prepared from either whole‐
blood donations or by plateletpheresis are superior. Usage of these two product types varies …
blood donations or by plateletpheresis are superior. Usage of these two product types varies …
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation
L Estcourt, S Stanworth, C Doree… - Cochrane Database …, 2012 - cochranelibrary.com
Background Platelet transfusions are used in modern clinical practice to prevent and treat
bleeding in thrombocytopenic patients with bone marrow failure. Although considerable …
bleeding in thrombocytopenic patients with bone marrow failure. Although considerable …
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological …
LJ Estcourt, SJ Stanworth, C Doree… - Cochrane Database …, 2015 - cochranelibrary.com
Background Platelet transfusions are used in modern clinical practice to prevent and treat
bleeding in people who are thrombocytopenic due to bone marrow failure. Although …
bleeding in people who are thrombocytopenic due to bone marrow failure. Although …
Platelet transfusion in adults: An update
O Garraud, H Hamzeh-Cognasse, E Chalayer… - Transfusion clinique et …, 2023 - Elsevier
Many patients worldwide receive platelet components (PCs) through the transfusion of
diverse types of blood components. PC transfusions are essential for the treatment of central …
diverse types of blood components. PC transfusions are essential for the treatment of central …
A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive …
GL Crighton, LJ Estcourt, EM Wood… - Cochrane Database …, 2015 - cochranelibrary.com
Background Platelet transfusions are used in modern clinical practice to prevent and treat
bleeding in thrombocytopenic patients with bone marrow failure. Although considerable …
bleeding in thrombocytopenic patients with bone marrow failure. Although considerable …
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell …
LJ Estcourt, S Stanworth, C Doree… - Cochrane Database …, 2015 - cochranelibrary.com
Background Platelet transfusions are used in modern clinical practice to prevent and treat
bleeding in people who are thrombocytopenic due to bone marrow failure. Although …
bleeding in people who are thrombocytopenic due to bone marrow failure. Although …
Use of random versus apheresis platelet concentrates
G Andreu, J Vasse, I Sandid, R Tardivel… - Transfusion clinique et …, 2007 - Elsevier
The respective use of random (RPC) and apheresis (APC) platelet concentrates is highly
heterogeneous among countries, ranging from 10 to 98% RPC in countries supposed to …
heterogeneous among countries, ranging from 10 to 98% RPC in countries supposed to …
Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries
A Haddad, T Elgemmezi, M Chaїb, T Bou Assi… - Vox …, 2020 - Wiley Online Library
Background and objectives Blood transfusion is inherently associated with risks, and little is
known regarding the available quality and safety measures in developing countries. No …
known regarding the available quality and safety measures in developing countries. No …
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation
G Christou, N Kekre, W Petrcich, M Tokessy… - …, 2015 - Wiley Online Library
Background Thrombocytopenia occurs commonly after hematopoietic progenitor cell
transplantation (HPCT) and is associated with potential morbidity and mortality. Few studies …
transplantation (HPCT) and is associated with potential morbidity and mortality. Few studies …